COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,780 Articles (22,946 medRxiv, 8,834 bioRxiv)

Most recent first Previous |  Page 2799: Articles 27981-27990  | Next

When Can Elimination of SARS-CoV-2 Infection be Assumed? Simulation Modelling in a Case Study Island Nation
Wilson, N., Parry, M., Verrall, A. J., Baker, M. G., Schwehm, M., Eichner, M.
10.1101/2020.05.16.20104240 — Posted: 2020-05-20 Discussion: Onsite
THE ROLE OF POINT-OF-CARE ULTRASONOGRAPHY IN THE INITIAL CHARACTERIZATION OF COVID-19 PATIENTS: RESULTS FROM A PROSPECTIVE MULTICENTRIC STUDY.
tung chen, y., Llamas Fuentes, R., Rodriguez Fuertes, P.
10.1101/2020.05.15.20103333 — Posted: 2020-05-20
COVID-19 in London, a Case Series Demonstrating Late Improvement in Survivors
Al-Hindawi, A., Sokhi, J., Cuddihy, J., Lockie, C., Christie, L., Davies, R., Singh, S., Vizcaychipi, M., Hayes, M., Sisson, A., Keays, R.
10.1101/2020.05.16.20103853 — Posted: 2020-05-20
IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections
Kimmig, L. M., Wu, D., Gold, M., Pettit, N. N., Pitrak, D., Mueller, J., Husain, A. N., Mutlu, E. A., Mutlu, G. M.
10.1101/2020.05.15.20103531 — Posted: 2020-05-20
Search for asymptomatic carriers of SARS-CoV-2 in healthcare workers during the pandemic: a Spanish experience
Olalla, J., Correa, A. M., Martin-Escalante, M. D., Hortas, M. L., Martin-Sendarrubias, M. J., Fuentes, V., Sena, G., Garcia-Alegria, J., ROBLE Group
10.1101/2020.05.18.20103283 — Posted: 2020-05-20
Differential Effects of Intervention Timing on COVID-19 Spread in the United States
Pei, S., Kandula, S., Shaman, J.
10.1101/2020.05.15.20103655 — Posted: 2020-05-20 Discussion: Onsite | Offsite
Monitoring the evolution of the COVID-19 pandemic in China, South Korea, Italy and USA through the net relative rate of infection of the total number of confirmed cases
Moreira, J. M. L.
10.1101/2020.05.15.20103259 — Posted: 2020-05-20
The specificity of Japanese PCR assays for SARS-CoV-2 exceeds 99.7%
Tsukadaira, A.
10.1101/2020.05.15.20103515 — Posted: 2020-05-20
Similar incidence of Coronavirus Disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy
Macias, J., Gonzalez-Moreno, P., Sanchez-Garcia, E., Morillo-Verdugo, R., Dominguez-Quesada, C., Pinilla, A., Macho, M., Martinez, M., Gonzalez-Serna, A., Corma, A., Real, L. M., Pineda, J. A.
10.1101/2020.05.16.20104141 — Posted: 2020-05-20
Preliminary evaluation of COVID-19 disease outcomes, test capacities and management approaches among African countries.
Otitoloju, A. A., Oluwole, E. O., Bawa-Allah, K. A., Fasona, M. J., Okafor, I. P., Isanbor, C., Osunkalu, V. O., Sowemimo, A. A., Keshinro, O. A., Aneyo, I. A., Folarin, O. S., Oladokun, A. A., Akinsola, O. J., Ayolabi, C. I., Egwuatu, T. O., Owoyomi, V. A., Ogbeibu, A. E.
10.1101/2020.05.16.20103838 — Posted: 2020-05-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).